" I do not know why MNTA waited nine days to make this filing."
The SEC was involved, requesting they file the entire document over again. My guess is a Reg. FD action, though original guidance from the SEC in such situations was to label 8-Ks used for that purpose accordingly.
Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC